Literature DB >> 17851009

[Cell Phones and Risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study].

M Hours1, M Bernard, L Montestrucq, M Arslan, A Bergeret, I Deltour, E Cardis.   

Abstract

BACKGROUND: Use of cell phones has increased dramatically since 1992 when they were first introduced in France. Certain electromagnetic fields (at extremely low frequency) have been recognized as possibly carcinogenic by the International Agency for Research on Cancer. Given the use of radiofrequency technology in cell phones, the rapid increase in the number of cell phones has generated concerns about the existence of a potential health hazard. To evaluate the relationship between the use of cell phones and the development of tumors of the head, a multicentric international study (INTERPHONE), coordinated by the International Agency for Research on Cancer, was carried out in 13 countries. This publication reports the results of the French part of the INTERPHONE study.
METHODS: INTERPHONE is a case-control study focused on tumors of the brain and central nervous system: gliomas, meningiomas and neuromas of cranial nerves. Eligible cases were men and women, residents of Paris or Lyon, aged 30-59, newly diagnosed with a first primary tumor between February 2001 and August 2003. The diagnoses were all either histologically confirmed or based upon unequivocal radiological images. Controls were matched for gender, age (+/-5 years) and place of residence. They were randomly drawn from electoral rolls. Detailed information was collected for all subjects during a computer-assisted face-to-face interview. Conditional logistic regression was used to estimate the odds ratio (OR) for an association between the use of cell phones and risk of each type of cancer.
RESULTS: Regular cell phone use was not associated with an increased risk of neuroma (OR=0,92; 95% confidence interval=[0.53-1.59]), meningioma (OR=0,74; 95% confidence interval=[0.43-1.28]) or glioma (OR=1.15; 95% confidence interval=[0.65-2.05]). Although these results are not statistically significant, a general tendency was observed for an increased risk of glioma among the heaviest users: long-term users, heavy users, users with the largest numbers of telephones.
CONCLUSION: No significant increased risk for glioma, meningioma or neuroma was observed among cell phone users participating in Interphone. The statistical power of the study is limited, however. Our results, suggesting the possibility of an increased risk among the heaviest users, therefore need to be verified in the international INTERPHONE analyses.

Entities:  

Mesh:

Year:  2007        PMID: 17851009     DOI: 10.1016/j.respe.2007.06.002

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  12 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Validation of self-reported occupational noise exposure in participants of a French case-control study on acoustic neuroma.

Authors:  Isabelle Deltour; Amélie Massardier-Pilonchery; Brigitte Schlehofer; Klaus Schlaefer; Martine Hours; Joachim Schüz
Journal:  Int Arch Occup Environ Health       Date:  2019-04-26       Impact factor: 3.015

3.  Human injury from atomic particles and photon exposure: fears, myths, risks, and mortality.

Authors:  Frank L Tabrah
Journal:  Hawaii Med J       Date:  2010-04

Review 4.  Mobile phone use and risk of brain tumours: a systematic review of association between study quality, source of funding, and research outcomes.

Authors:  Manya Prasad; Prachi Kathuria; Pallavi Nair; Amit Kumar; Kameshwar Prasad
Journal:  Neurol Sci       Date:  2017-02-17       Impact factor: 3.307

5.  The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study.

Authors:  Kathrine Grell; Kirsten Frederiksen; Joachim Schüz; Elisabeth Cardis; Bruce Armstrong; Jack Siemiatycki; Daniel R Krewski; Mary L McBride; Christoffer Johansen; Anssi Auvinen; Martine Hours; Maria Blettner; Siegal Sadetzki; Susanna Lagorio; Naohito Yamaguchi; Alistair Woodward; Tore Tynes; Maria Feychting; Sarah J Fleming; Anthony J Swerdlow; Per K Andersen
Journal:  Am J Epidemiol       Date:  2016-11-03       Impact factor: 4.897

Review 6.  Current state of our knowledge on brain tumor epidemiology.

Authors:  Quinn T Ostrom; Jill S Barnholtz-Sloan
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

7.  Emerging aspects of mobile phone use.

Authors:  F Samkange-Zeeb; M Blettner
Journal:  Emerg Health Threats J       Date:  2009-06-12

8.  Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies - how do they arise?

Authors:  Angelo G Levis; Nadia Minicuci; Paolo Ricci; Valerio Gennaro; Spiridione Garbisa
Journal:  Environ Health       Date:  2011-06-17       Impact factor: 5.984

9.  Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries.

Authors:  E Cardis; B K Armstrong; J D Bowman; G G Giles; M Hours; D Krewski; M McBride; M E Parent; S Sadetzki; A Woodward; J Brown; A Chetrit; J Figuerola; C Hoffmann; A Jarus-Hakak; L Montestruq; L Nadon; L Richardson; R Villegas; M Vrijheid
Journal:  Occup Environ Med       Date:  2011-06-09       Impact factor: 4.402

10.  Estimation of RF energy absorbed in the brain from mobile phones in the Interphone Study.

Authors:  E Cardis; N Varsier; J D Bowman; I Deltour; J Figuerola; S Mann; M Moissonnier; M Taki; P Vecchia; R Villegas; M Vrijheid; K Wake; J Wiart
Journal:  Occup Environ Med       Date:  2011-06-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.